Tenofovir-induced osteopenia and hyperparathyroidism: A case report and literature review

被引:0
|
作者
Zeng, Jing [1 ]
Ye, Peng [1 ]
Wei, Dong [1 ]
Li, Lan [1 ]
Ma, Wanxia [1 ]
机构
[1] Chengdu Second Peoples Hosp, Dept Endocrinol & Metab, Chengdu, Sichuan, Peoples R China
来源
关键词
tenofovir disoproxil fumarate; osteopenia; hyperparathyroidism; 25-hydroxy vitamin D; chronic viral hepatitis B; BONE-MINERAL DENSITY; CHRONIC HEPATITIS-B; DISOPROXIL FUMARATE; VITAMIN-D; ANTIRETROVIRAL THERAPY; PARATHYROID-HORMONE; COMBINATION THERAPY; CALCIUM; OSTEOPOROSIS; MONOTHERAPY;
D O I
10.3389/fendo.2022.1043954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tenofovir disoproxil fumarate is the first-line antiviral therapy for chronic viral hepatitis B, but long-term use is associated with renal failure and hypophosphatemic osteomalacia. Tenofovir disoproxil fumarate-induced osteoporosis and secondary hyperparathyroidism are less commonly reported. Herein, we describe the case of a patient with bone and multijoint pain who was initially misdiagnosed as having normocalcemic primary hyperparathyroidism associated with prolonged exposure to tenofovir disoproxil fumarate. The patient's 24-h urinary calcium and phosphorus excretion levels and serum calcium levels were at the lower end of the normal range. After reviewing these findings, the diagnosis was amended to osteoporosis and secondary hyperparathyroidism caused by tenofovir disoproxil fumarate. In this report, we describe the differences in clinical and laboratory manifestations of hyperparathyroidism induced by tenofovir disoproxil fumarate and normocalcemic primary hyperparathyroidism. We also discuss relevant pathophysiological mechanisms and propose a feasible treatment strategy.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Early onset of tenofovir-induced renal failure: Case report and review of the literature
    Patel, Shilpa M.
    Zembower, Teresa R.
    Palella, Frank
    Kanwar, Yashpal S.
    Ahya, Shubhada N.
    [J]. THESCIENTIFICWORLDJOURNAL, 2007, 7 : 1140 - 1148
  • [2] Tenofovir-Induced Osteomalacia
    Anastasopoulou, Catherine
    Lekprasert, Patamaporn
    Blocher, Nissa
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [3] Tenofovir-Induced Osteoporosis
    Gunal, Ozgur
    Guzel, Nizamettin
    Koksal, Eda
    Atilla, Aynur
    Kilic, Sirri
    [J]. KLIMIK JOURNAL, 2016, 29 (03) : 142 - 143
  • [4] Tenofovir-induced osteomalacia
    Wanner, D. P.
    Tyndall, A.
    Walker, U. A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (06) : 1001 - 1003
  • [5] Tenofovir-induced osteomalacia with hypophosphataemia
    Iatan, Iulia
    Lee, Todd C.
    McDonald, Emily G.
    [J]. BMJ CASE REPORTS, 2021, 14 (05)
  • [6] First reported case of tenofovir-induced photoallergic reaction
    Verma, Rajesh
    Vasudevan, Biju
    Shankar, Subramanian
    Pragasam, Vijendran
    Suwal, Bhabendra
    Venugopal, Ruby
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (05): : 651 - 653
  • [7] Tenofovir-Induced Bullous Lesions
    Khanijao, Suchit
    Kitchloo, Karishma
    Kamath, Anisha
    Dancy, Leah
    Gour, Animesh
    Saxena, Abhinav
    [J]. CHEST, 2016, 150 (04) : 19A - 19A
  • [8] TENOFOVIR-INDUCED TYPE II RENAL TUBULAR ACIDOSIS AND FANCONI SYNDROME: A CASE REPORT
    Saeed, Mariam
    Khan, Muneer
    Nalamati, Jhansi
    [J]. CHEST, 2019, 156 (04) : 1938A - 1938A
  • [9] Tenofovir-Induced Fanconi Syndrome
    Hatch, Alexandria
    Michaels, Anthony
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S330 - S330
  • [10] Tenofovir-induced kidney injury
    Gitman, Michael D.
    Hirschwerk, David
    Baskin, Cindy H.
    Singhal, Pravin C.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2007, 6 (02) : 155 - 164